Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1615
This examiner grants 29% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18105990 | SURFACE TREATMENT OF POLY(ARYL ETHER KETONE)S | Non-Final OA | FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG e. V. |
| 18591127 | Methods, Systems and Devices for Post-Fabrication Drug Loading | Non-Final OA | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL |
| 18029619 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF IMPLANT ASSOCIATED COMPLICATIONS | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 18718158 | Compositions for Virulence Suppression | Non-Final OA | Solventum Intellectual Properties Company |
| 17556093 | DUAL AGENT NANOPARTICLE COMPOSITION FOR COATING MEDICAL DEVICES | Final Rejection | THE CLEVELAND CLINIC FOUNDATION |
| 18423951 | SURGICAL SYSTEM AND METHODS OF USE | Final Rejection | Medtronic, Inc. |
| 18140510 | ANTIMICROBIAL CATHETER COATINGS WITH PASSIVE ANTIFUNGAL PROPERTIES | Non-Final OA | Becton, Dickinson and Company |
| 17675334 | MEDICAL DEVICE AND METHOD FOR MANUFACTURING SAME | Final Rejection | TERUMO KABUSHIKI KAISHA |
| 18877255 | STABILIZATION OF THIOPYRIDINONE COMPOUND AND COMPOSITION COMPRISING SAME | Non-Final OA | L'OREAL |
| 18543756 | COMPOSITIONS CONTAINING BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE AND AVOBENZONE | Final Rejection | L'OREAL |
| 18254312 | RAPIDLY RESORBABLE INTRAVASCULAR IMPLANT | Non-Final OA | BIOTRONIK AG |
| 17629639 | WATER BASED COMPOSITION | Final Rejection | Shiseido Company, Ltd. |
| 18122661 | METHOD OF MANUFACTURING MICELLES FOR DRUG DELIVERY | Final Rejection | Wisconsin Alumni Research Foundation |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy